AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32333158 — intervention group
Group type: EXPERIMENTAL
Intervention: TaTME (Transanal Total Mesorectal Excision)
Number of subjects: 173
Study 36335415 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin
Number of subjects: 34
Study 36335415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 32586771 — intervention group
Group type: EXPERIMENTAL
Intervention: Compatible crossmatches (n=39)
Number of subjects: 50
Study 32586771 — intervention group
Group type: EXPERIMENTAL
Intervention: Incompatible crossmatches (n=11)
Number of subjects: 50
Study 32586771 — intervention group
Group type: COMPARATOR
Intervention: Comparison of compatible vs incompatible crossmatches
Number of subjects: 50
Study 34482851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes with produce allocations (PAE)
Number of subjects: 120
Study 34482851 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education and cooking classes only (EO)
Number of subjects: 120
Study 34482851 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 36286834 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective VDRA (zemplar 1 mcg/day)
Number of subjects: 90
Study 36286834 — intervention group
Group type: COMPARATOR
Intervention: Non-selective VDRA (alfacalcidol 0.25 mcg/day)
Number of subjects: 90
Study 32712967 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestive seizure induction (group A)
Number of subjects: 77
Study 32712967 — intervention group
Group type: COMPARATOR
Intervention: Long-term video–electroencephalography (EEG) monitoring (group B)
Number of subjects: 77
Study 32712967 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestive seizure induction
Number of subjects: 77
Study 32712967 — intervention group
Group type: COMPARATOR
Intervention: Long-term monitoring
Number of subjects: 77
Study 32712967 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous PNES during long-term monitoring
Number of subjects: 77
Study 35598547 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Ayurveda and mindfulness-based Yoga (CAY)
Number of subjects: 356
Study 35598547 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 356
Study 32569068 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical vancomycin powder (1000 mg)
Number of subjects: 58
Study 34574383 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPROVEjob intervention (two leadership workshops, toolbox with printed and online material, nine-month implementation phase)
Number of subjects: 366
Study 34574383 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPROVEjob intervention
Number of subjects: 366
Study 34574383 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 366
Study 32179870 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dairy group (RDa; 4 servings/day)
Number of subjects: 35
Study 32179870 — intervention group
Group type: COMPARATOR
Intervention: Low dairy group (LDa; 0–2 servings/day)
Number of subjects: 35
Study 32179870 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RDa and LDa)
Number of subjects: 35
Study 36410628 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine-prilocaine
Number of subjects: 90
Study 36410628 — intervention group
Group type: COMPARATOR
Intervention: Ice packs
Number of subjects: 90
Study 34420949 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supplementation with 2.3 g of omega-3 fatty acids (n-3 FAs)
Number of subjects: 33
Study 34420949 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 35061783 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect‐to‐Dads
Number of subjects: 857
Study 35061783 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct‐to‐Dads
Number of subjects: 857
Study 35061783 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey completion method
Number of subjects: 857
Study 35061783 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare access
Number of subjects: 857
Study 35061783 — intervention group
Group type: EXPERIMENTAL
Intervention: Health behaviors
Number of subjects: 857
Study 35428642 — intervention group
Group type: EXPERIMENTAL
Intervention: Work schedule without quick returns for 6 months
Number of subjects: 4000
Study 35428642 — intervention group
Group type: COMPARATOR
Intervention: Work schedule that maintains quick returns for 6 months
Number of subjects: 4000
Study 32577707 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish with functionalized tri‐calcium phosphate (fTCP) applied at baseline and after 8 weeks
Number of subjects: 59
Study 32577707 — intervention group
Group type: COMPARATOR
Intervention: Fluoride-free mock product (Control)
Number of subjects: 59
Study 35899748 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day cholecalciferol (vitamin D) for 5 years
Number of subjects: 1000
Study 35899748 — intervention group
Group type: EXPERIMENTAL
Intervention: 1g/day omega-3 fatty acids for 5 years
Number of subjects: 1000
Study 35899748 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2000 IU/day vitamin D and 1g/day omega-3 fatty acids for 5 years
Number of subjects: 1000
Study 35899748 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D after 2 years
Number of subjects: 1000
Study 34741088 — intervention group
Group type: EXPERIMENTAL
Intervention: THC-dominant concentrate
Number of subjects: 0
Study 34741088 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD-dominant concentrate
Number of subjects: 0
Study 35897060 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil plus panitumumab (6 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Number of subjects: 153
Study 35897060 — intervention group
Group type: COMPARATOR
Intervention: Trifluridine/tipiracil plus bevacizumab (5 mg/kg body weight, intravenously on day 1 and 15, q28 days)
Number of subjects: 153
Study 34072155 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantum Dots (QDs)
Number of subjects: 0
Study 34072155 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibliometric model for qualitative and quantitative evaluation
Number of subjects: 0
Study 36096430 — intervention group
Group type: EXPERIMENTAL
Intervention: SpikoGen®
Number of subjects: 16876
Study 36096430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16876
Study 33604666 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate mixed linear model
Number of subjects: 172
Study 32992898 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus, L. casei, L. helveticus, Bifidobacterium bifidum) for 60 days (n = 8)
Number of subjects: 28
Study 32992898 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 28
Study 32992898 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/restricted dietary fiber (n = 12)
Number of subjects: 28
Study 32992898 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/adequate dietary fiber (n = 10)
Number of subjects: 28
Study 32992898 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate protein/restricted dietary fiber (n = 6)
Number of subjects: 28
Study 32992898 — intervention group
Group type: COMPARATOR
Intervention: Healthy sedentary subjects (n = 15)
Number of subjects: 28
Study 34481963 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 100
Study 34481963 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 100
Study 32978696 — intervention group
Group type: COMPARATOR
Intervention: Melatonin (MLT) 40 mg/kg
Number of subjects: 3
Study 32978696 — intervention group
Group type: COMPARATOR
Intervention: Folic acid (FA) 2 mg/kg
Number of subjects: 3
Study 32978696 — intervention group
Group type: COMPARATOR
Intervention: Melatonin + Folic acid (MLT + FA)
Number of subjects: 3
Study 32978696 — intervention group
Group type: COMPARATOR
Intervention: All experimental diets (including MLT, FA, MLT + FA)
Number of subjects: 3
Study 32978696 — intervention group
Group type: COMPARATOR
Intervention: Control diet (basal diet)
Number of subjects: 3
Study 35606865 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotic bowel preparation (OABP) with neomycin 1 g and metronidazole 0.9 g the day before surgery
Number of subjects: 1500
Study 35606865 — intervention group
Group type: COMPARATOR
Intervention: No special intestinal preparation (control group)
Number of subjects: 1500
Study 33632187 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc-Blue
Number of subjects: 30
Study 33632187 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne-Gold
Number of subjects: 30
Study 33632187 — intervention group
Group type: EXPERIMENTAL
Intervention: XP-EndoShaper
Number of subjects: 30
Study 35093842 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Processing Intervention (EMOPRINT), a 12-session behavioral intervention teaching facial affect recognition skills and mimicry.
Number of subjects: 36
Study 35093842 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group (no specific intervention details provided).
Number of subjects: 36
Study 33068445 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-point intramuscular injection technique (8-12 units of incobotulinumtoxinA)
Number of subjects: 48
Study 33068445 — intervention group
Group type: COMPARATOR
Intervention: 6-point intradermal injection technique (8-12 units of incobotulinumtoxinA)
Number of subjects: 48
Study 33068445 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-point intramuscular injection technique
Number of subjects: 48
Study 33068445 — intervention group
Group type: COMPARATOR
Intervention: 6-point intradermal injection technique
Number of subjects: 48
Study 35881942 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-Meno
Number of subjects: 0
Study 35881942 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 0
Study 34111160 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-elbow cast (AE)
Number of subjects: 128
Study 34111160 — intervention group
Group type: COMPARATOR
Intervention: Below-elbow cast (BE)
Number of subjects: 128
Study 35092418 — intervention group
Group type: EXPERIMENTAL
Intervention: Letibotulinumtoxin A (20 U)
Number of subjects: 355
Study 35092418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 33236464 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus add-on linagliptin
Number of subjects: 50
Study 33236464 — intervention group
Group type: COMPARATOR
Intervention: Increased dose of metformin
Number of subjects: 50
Study 35767683 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic range-of-motion exercises (30-minute weekly sessions)
Number of subjects: 50
Study 35767683 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study 32870583 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal chemical trigeminal stimulation with carbon dioxide
Number of subjects: 24
Study 34687654 — intervention group
Group type: EXPERIMENTAL
Intervention: AGN‐151607 (botulinum toxin type A) 125 U (25 U / fat pad)
Number of subjects: 330
Study 34687654 — intervention group
Group type: EXPERIMENTAL
Intervention: AGN‐151607 (botulinum toxin type A) 250 U (50 U / fat pad)
Number of subjects: 330
Study 34687654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 32213023 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.1
Number of subjects: 319
Study 32213023 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.2
Number of subjects: 319
Study 32213023 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP with IQR/median <0.3
Number of subjects: 319
Study 32213023 — intervention group
Group type: COMPARATOR
Intervention: CAP with IQR <40 dB/m
Number of subjects: 319
Study 33992276 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck stabilization exercise
Number of subjects: 45
Study 33992276 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise
Number of subjects: 45
Study 33992276 — intervention group
Group type: COMPARATOR
Intervention: Neck dynamic isometric exercise
Number of subjects: 45
Study 33160359 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (10 mg/kg) plus docetaxel (75 mg/m2)
Number of subjects: 530
Study 33160359 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 530
Study 33160359 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (10 mg/kg) plus docetaxel
Number of subjects: 530
Study 35396295 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant result (SSR) without spin
Number of subjects: 297
Study 35396295 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistically significant result with spin
Number of subjects: 297
Study 35396295 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-statistically significant result with spin
Number of subjects: 297
Study 35396295 — intervention group
Group type: COMPARATOR
Intervention: Non-SSR without spin
Number of subjects: 297
Study 33386826 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy combined with cycling exercise (cycle ergometer session for five consecutive days)
Number of subjects: 20
Study 33386826 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (twice a day)
Number of subjects: 20
Study 32151044 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing meetings
Number of subjects: 173
Study 32151044 — intervention group
Group type: COMPARATOR
Intervention: Walking meetings
Number of subjects: 173
Study 34181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Rg1 (5 mg) supplementation 1 hour before squat exercise
Number of subjects: 12
Study 34181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat exercise
Number of subjects: 12
Study 34181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Rg1 (5 mg) supplementation
Number of subjects: 12
Study 34181580 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 33508141 — intervention group
Group type: EXPERIMENTAL
Intervention: Alexandrite laser alone
Number of subjects: 36
Study 33508141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd YAG laser alone
Number of subjects: 36
Study 33508141 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended 755/1064 nm laser
Number of subjects: 36
Study 33508141 — intervention group
Group type: EXPERIMENTAL
Intervention: 70/30 mixture of Nd:YAG and alexandrite
Number of subjects: 36
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical laboratory services satisfaction
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing laboratory request form
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Legibility and completeness of laboratory report
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification of new test
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Test interruption
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of laboratory hand book
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing test menu
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Lab-physician interface
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of referral and/or back up service
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification of Turn Around Time (TAT)
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely notification of panic result
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Long Turn Around Time (TAT)
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of urgent service
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Timely advisory service
Number of subjects: 327
Study 32353001 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent quality of service delivery
Number of subjects: 327
Study 35550371 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard opioid prescription (ten 5-mg oxycodone tablets provided preoperatively)
Number of subjects: 82
Study 35550371 — intervention group
Group type: COMPARATOR
Intervention: Restricted opioid prescription (provided only during patient request postoperatively)
Number of subjects: 82
Study 35550371 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (using opioids)
Number of subjects: 82
Study 35550371 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard arm
Number of subjects: 82
Study 35550371 — intervention group
Group type: COMPARATOR
Intervention: Restricted arm
Number of subjects: 82
Study 34325831 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study 34325831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study 32652462 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly SMS reminder
Number of subjects: 244
Study 32652462 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 244
Study 35382842 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK228 plus weekly paclitaxel
Number of subjects: 124
Study 35382842 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel alone (standard treatment)
Number of subjects: 124
Study 33863242 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert Recommendations for Implementing Change strategies
Number of subjects: 0
Study 32560503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet Therapy (KDT) including classic ketogenic diet (cKD), modified Atkins diet (MAD), medium chain triglyceride ketogenic diet (MCTKD), low glycemic index treatment (LGIT)
Number of subjects: 0
Study 34028038 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective learning method
Number of subjects: 70
Study 34028038 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 32518064 — intervention group
Group type: EXPERIMENTAL
Intervention: SU (glimepiride 1 mg) + GIP (1.5 pmol/kg/min)
Number of subjects: 20
Study 32518064 — intervention group
Group type: EXPERIMENTAL
Intervention: SU (glimepiride 1 mg) + GLP-1 (0.5 pmol/kg/min)
Number of subjects: 20
Study 32518064 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo + saline)
Number of subjects: 20
Study 32518064 — intervention group
Group type: EXPERIMENTAL
Intervention: SU (glimepiride 1 mg) + placebo
Number of subjects: 20
Study 32518064 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 20
Study 32518064 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 20
Study 35955129 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric hamstring training (6 weeks, twice weekly) in post-PHV group
Number of subjects: 45
Study 35955129 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric hamstring training (6 weeks, twice weekly) in pre-PHV group
Number of subjects: 45
Study 35955129 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-PHV)
Number of subjects: 45
Study 35955129 — intervention group
Group type: COMPARATOR
Intervention: Control group (post-PHV)
Number of subjects: 45
Study 34531424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified physiotherapy (n=22)
Number of subjects: 47
Study 34531424 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy (n=25)
Number of subjects: 47
Study 34531424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 35664039 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyp-based strategy
Number of subjects: 944
Study 35664039 — intervention group
Group type: COMPARATOR
Intervention: Optical diagnosis for small polyps (< 10 mm)
Number of subjects: 944
Study 35664039 — intervention group
Group type: COMPARATOR
Intervention: Optical diagnosis
Number of subjects: 944
Study 33307906 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support (LPS) with vaginal progesterone
Number of subjects: 59
Study 33307906 — intervention group
Group type: COMPARATOR
Intervention: No luteal phase support (No-LPS)
Number of subjects: 59
Study 34583626 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulation Focused Psychotherapy for Children (RFP-C)
Number of subjects: 43
Study 34583626 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 43
Study 34631028 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised text message (early)
Number of subjects: 194
Study 34631028 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised text message (late)
Number of subjects: 194
Study 34631028 — intervention group
Group type: COMPARATOR
Intervention: Non-personalised text message (early)
Number of subjects: 194
Study 34631028 — intervention group
Group type: COMPARATOR
Intervention: Non-personalised text message (late)
Number of subjects: 194
Study 33049804 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812 (1,800 mg)
Number of subjects: 0
Study 33049804 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 0
Study 33049804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32279063 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted smartphone application (TSPA)
Number of subjects: 48
Study 32279063 — intervention group
Group type: COMPARATOR
Intervention: Non-programmable calculator (NPC)
Number of subjects: 48
Study 33006755 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 99
Study 33006755 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 99
Study 32515065 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-fatigue of the diaphragm (PTL) prior to exercise
Number of subjects: 16
Study 32515065 — intervention group
Group type: COMPARATOR
Intervention: No PTL (control)
Number of subjects: 16
Study 36374508 — intervention group
Group type: EXPERIMENTAL
Intervention: ICM monitoring
Number of subjects: 496
Study 36374508 — intervention group
Group type: COMPARATOR
Intervention: Site-specific usual care (short-duration external cardiac monitoring)
Number of subjects: 496